Page last updated: 2024-11-06

3-(dimethylamino)benzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(dimethylamino)benzoic acid, also known as meta-dimethylaminobenzoic acid, is an organic compound with the formula C9H11NO2. It is a white solid that is soluble in water. It is a versatile building block for the synthesis of other compounds, including pharmaceuticals, dyes, and polymers. The compound is a precursor to the local anesthetic benzocaine. It is synthesized by the reaction of m-aminobenzoic acid with dimethyl sulfate. The compound has been studied for its potential as a corrosion inhibitor, as well as for its anti-inflammatory and antioxidant properties. It is also used in the production of photographic developers and as a component in some hair dyes.'

3-(dimethylamino)benzoic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID66837
CHEMBL ID111877
SCHEMBL ID222176
MeSH IDM0090740

Synonyms (41)

Synonym
m-(dimethylamino)benzoic acid
benzoic acid, 3-(dimethylamino)-
99-64-9
3-(dimethylamino)benzoic acid
benzoic acid, m-(dimethylamino)-
nsc-7197
nsc7197
n,n-dimethyl-m-aminobenzoic acid
m-dimethylaminobenzoic acid
STK426307
3-(dimethylamino)benzoic acid, >=97% (hplc)
AC-2474
3-dimethylaminobenzoic acid
D0646
3-dimethylamino-benzoic acid
CHEMBL111877
AKOS000119534
A846058
3-(dimethylamino)benzoate
nsc 7197
einecs 202-775-2
AE-562/40173868
FT-0615605
SCHEMBL222176
3-(dimethylamino) benzoic acid
3-dimethylamino benzoic acid
3-n,n-dimethylaminobenzoic acid
3-(n,n-dimethylamino)benzoic acid
DTXSID7059199
W-100025
TS-02213
mfcd00002497
F0001-2337
CS-W018494
m-(n,n'-dimethylamino)benzoic acid
Q63409854
D70678
SB76539
EN300-20121
M47AQ3FS7E
Z104476962
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID28693Concentration of the drug in the liver of rat1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1060462Inhibition of Sir2p in yeast DMY2844 assessed as growth inhibition at 800 uM after 48 hrs2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Evaluation of benzoic acid derivatives as sirtuin inhibitors.
AID28692Concentration of the drug in the kidney of rat1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's3 (33.33)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.41 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]